Doxil doxorubicin regulatory update

FDA approved an sNDA from Johnson & Johnson for Doxil doxorubicin liposome injection to treat AIDS-related Kaposi's sarcoma after failure of, or intolerance to, systemic chemotherapy. The company mar...